Application
Efavirenz has been used:to assess its anti-porcine endogenous retrovirus (PERV) activityin cytotoxicity assayto investigate the solute-solvent effects of efavirenz by means combined time-dependent density functional theory (TD-DFT) and spectroscopic calculations
Biochem/physiol Actions
Efavirenz is a nonnucleoside reverse transcriptase inhibitor (NNRTI). It is an anti-HIV drug, commonly used in combination therapy for AIDs treatment. It is part of highly active antiretroviral therapy (HAART) for the treatment of a human immunodeficiency virus (HIV) type 1.
Features and Benefits
This compound is a featured product for ADME Tox research. Click here to discover more featured ADME Tox products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
General description
Efavirenz, commercially known as Sustiva™ is a polycyclic aromatic hydrocarbon with benzene and oxazinan-2-one chromophores.
Legal Information
Sustiva is a trademark of E. I. du Pont de Nemours and Company
Packaging
10, 50 mg in glass bottle
This product has met the following criteria to qualify for the following awards: